BriaCell Therapeutics Corp. reports

Company location: West Vancouver, British Columbia, Canada
Fiscal year end: 31 July

BriaCell Therapeutics Corp. has filed 323 SEC EDGAR filings since 20 Jun 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
40-F
6-K

SEC filing history

Showing 1-4 of 4 matching filings.

Per page

25

Current page

1

10-K File 001-40101

10-K

Filing date: 16 Oct 2025
Reporting date: 31 Jul 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40101

10-K filing

Filing date: 29 Oct 2024
Reporting date: 31 Jul 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40101

10-K filing

Filing date: 25 Oct 2023
Reporting date: 31 Jul 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40101

10-K filing

Filing date: 28 Oct 2022
Reporting date: 31 Jul 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .